-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Reiterates Buy on Ascentage Pharma Group, Maintains $48 Price Target

Benzinga·11/17/2026 12:48:16
Listen to the news
BTIG analyst Jeet Mukherjee reiterates Ascentage Pharma Group (NASDAQ:AAPG) with a Buy and maintains $48 price target.